Here is Fred's response to my OFF-LABEL thought.Hi ......,
There is always off-label usage even though as a company we will not promote such usage. Our goal is to have plasminogen established as an hospital product used in many different indications. We will provide more information on our plan for Pg at the analyst day. We have developed a different formulation already for wound healing and it will be used in the upcoming wound healing trial in Sweden. For hard to treat wounds, as you know there will be micro-injection of Pg in small quantities, intra-dermal around the wound. More to come on the study protocol once the CTA is cleared. We will not even try to quantify sales for indications not yet approved or off-label usage.
Thx
Regards
Fred
Frdric Dumais, B. Comm., LLB.
Directeur principal, Communications et relations avec les investisseurs
Senior Director, Communications and Investor Relations
ProMetic Sciences de la Vie inc.
ProMetic Life Sciences Inc.